Translating today's discoveries in childhood cancer research into tomorrow's treatments.

One of only two institutes in the United States dedicated solely to pediatric cancer research, the Greehey Children’s Cancer Research Institute, with its 18 laboratories, focuses its strengths in cancer genomics, DNA repair, RNA biology, and drug development to find new and less toxic treatments for childhood cancers.

Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.

Learn More


Help Make a Difference

Top stories

Houghton & Kurmasheva
Drs Houghton and Kurmasheva to Receive $2.9M NCI Pediatric In Vivo Testing Program(PIVOT) U01 Grant Renewal
Science Advances
Science Advances: Predicting and characterizing a cancer dependency map of tumors with deep learning (Aune, Chen, Rao, Houghton & Zheng Labs)
Yogesh Gupta PhD
5-year $3.0 million R01 NIH/NIAID Grant Awarded to Yogesh Gupta, PhD. 
Cancer Research
Cancer Research: SNAI2-mediated repression of BIM protects rhabdomyosarcoma from ionizing radiation (Houghton, Ignatius, & Zheng Labs)

Featured Video

News



View all news

Events